Satellite Bio develops Tissue Therapeutics that utilize expanded, mature hepatocyte cells for the treatment of liver dysfunction. Their Satellite Adaptive Tissue Platform enables the precise delivery and durable engraftment of these living cells to restore critical organ function.
Funding
$82.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current treatments for liver dysfunction often fall short, with limited options for restoring critical organ function and addressing the underlying causes of disease. Traditional approaches may not effectively deliver therapeutic cells to the liver or ensure their long-term survival and integration within the tissue.
Solution
Satellite Bio is developing Tissue Therapeutics, a novel approach to regenerative medicine that utilizes expanded, mature hepatocytes to treat liver dysfunction. Their Satellite Adaptive Tissue (SAT) Platform enables the precise delivery and durable engraftment of these living cells, aiming to restore critical organ function. The platform leverages key technological innovations in cell expansion, seed formation, and stabilization to unlock the broad application of solid organ cells as therapeutic agents. By delivering healthy, living cells directly to the site of damage, Satellite Bio seeks to provide tailored therapies that address a range of severe, life-threatening liver diseases.
Target Audience
The primary target audience includes patients suffering from liver dysfunction and related diseases, as well as clinicians and researchers seeking innovative regenerative medicine solutions.
Features
- Expansion of mature hepatocytes to generate a sufficient supply of therapeutic cells.
- Seed formation technology to create organized clusters of cells for improved delivery and engraftment.
- Stabilization techniques to enhance cell survival and integration within the target tissue.
- Precise delivery methods to ensure cells reach the intended location within the liver.
- Durable engraftment strategies to promote long-term cell survival and function.
- Customizable therapy approach to tailor treatments to different diseases and patients.